Buy Maball : Rituximab 500 mg/50 ml Injection Online

$342.45

Brand Name : Maball
Composition : Rituximab
Manufactured by : Hetero Ltd.
Strength : 500mg
Form : Injection
Packing : Pack of 1 Vial

Prescription required *

- +
Compare
SKU: 339435 Category:

Description

Product Overview: Maball is a potent medication designed to target specific cells in the immune system, particularly B-lymphocytes, which are involved in certain autoimmune diseases and cancers. Each vial of Maball contains 500 mg of Rituximab, the active pharmaceutical ingredient renowned for its efficacy in treating various conditions. Manufactured to the highest quality standards by Hetero Ltd., Maball offers reliability and therapeutic excellence in immunotherapy.

Key Features:

  • Immunomodulatory Agent: Maball contains Rituximab, a monoclonal antibody that selectively targets CD20-positive B-cells, effectively modulating the immune response in autoimmune diseases and malignancies.
  • Precision Therapy: By specifically targeting B-lymphocytes, Maball helps to mitigate disease activity while preserving vital immune functions.
  • Convenient Dosage Form: Each vial of Maball contains a sterile solution of 500 mg Rituximab in a 50 ml formulation, providing healthcare professionals with a convenient and reliable dosage option for patient administration.
  • Manufactured by Hetero Ltd.: Maball is manufactured by Hetero Ltd., a renowned pharmaceutical company known for its commitment to quality, innovation, and affordability in healthcare.

Indications: Maball is indicated for the treatment of various autoimmune diseases, including rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and certain types of lymphomas, such as non-Hodgkin’s lymphoma and chronic lymphocytic leukemia.

Usage Instructions: Maball should be administered under the supervision of a qualified healthcare professional experienced in the use of immunosuppressive agents. The dosage and frequency of administration may vary depending on the specific condition being treated, patient response, and other factors. It is essential to follow the prescribing physician’s instructions carefully.

Safety Information:

  • Prior to initiating treatment with Maball, patients should undergo thorough evaluation, including assessment of baseline blood counts, immune function, and screening for infections.
  • Adverse reactions such as infusion-related reactions, infections, and hematologic abnormalities may occur during or after treatment with Maball. Patients should be monitored closely for any signs of adverse effects and managed accordingly.
  • Maball may increase the risk of certain infections, including reactivation of hepatitis B virus. Patients should be screened for latent infections before starting treatment and monitored for signs of infection during therapy.
  • Use of Maball during pregnancy or breastfeeding should be carefully considered, weighing the potential risks and benefits to the mother and fetus.

Storage: Maball should be stored as per the manufacturer’s instructions, typically at controlled room temperature away from light and moisture. Unused portions should be discarded according to local regulations.

Disclaimer: The information provided here is for educational purposes only and does not substitute medical advice. Patients should consult their healthcare provider for personalized recommendations and treatment options.